Generating evidence to elevate your product's value proposition and reimbursement potential

We apply established methods and innovative tailored solutions to meet specific HTA challenges, support market access and bolster arguments for product reimbursement. By leveraging our extensive global expertise in health economics and market access strategy, ICON provides clients with the tools they need to successfully communicate product value to all stakeholders. We deliver practical,actionable, and scientifically credible research and guidance that can be fully integrated into the development and commercialisation process. Our experts help you to:

Define Value Proposition

  • Value story and messaging development
  • Global value and reimbursement dossiers
  • HTA and payer evidence needs assessments
  • Economic advisory boards

Integrate with Clinical Development

  • Payer-relevant endpoints for clinical trials
  • Training solutions
  • Development of study designs and protocols

Differentiate your Product and Expand to New Markets

  • Define product position
  • Secondary database analyses
  • Analyses of adherence, compliance, and convenience data

Generate and Communicate Evidence for HTAs and Payers

  •  Cost-effectiveness analyses
  •  Economic modelling
  •  Systematic literature reviews and critical appraisal
  •  Network meta-analysis and indirect treatment comparisons
  •  HEOR strategic planning pre- and post-launch
  • Local model adaptations and reimbursement submissions
  • Peer-reviewed publications

Support New Product Opportunities

  • Regulatory and policy impact evaluation
  • Patient and physician surveys and focus groups
  • Payer value message testing
  • Practice pattern analyses to identify new positioning

By leveraging our extensive global expertise across clinical, payer, commercial and health economic domains, we develop innovative strategies and generate rigorous evidence to communicate product value to all stakeholders.